omidenepag isopropyl ophthalmic (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Glaucoma

Pending FDA approval for glaucoma and ocular hypertension

Next:

Pharmacology

Mechanism of Action

Selective prostaglandin E2 receptor (EP2) agonist

Hydrolyzes to release its active free acid form (omidenepag) into the aqueous humor after topical ocular instillation

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.